N/A
N=610
Monitoring and Evaluation of Micronutrients (Sprinkles) Project
Anemia
Bottom Line
View on ClinicalTrials.gov: NCT00659061 ↗Enrolled (actual)
610
Serious AEs
—
Results posted
May 2009
Primary outcome: Primary: Number of Participants With Anemia — 185; 172; 139; 191 participants — p=0.32
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- SPRINKLES (Dietary_supplement); Nutrition education (Behavioral)
- Age
- Pediatric · 0+ yrs
- Sex
- All
- Sponsor
- Aga Khan University
- Primary completion
- Apr 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Participants With Anemia |
185; 172; 139; 191 | 0.32 |
| PRIMARY Number of Participants With Moderate to Severe Anemia |
114; 102; 84; 138 | 0.34 |
| PRIMARY Mean Hemoglobin of Participants Post Intervention |
10.97; 9.98 | 0.000 sig |
| SECONDARY Vitamin A Status of Participants - Post Intervention |
74; 115; 96; 89; 62; 28 | — |
| SECONDARY Mean Vitamin A Serum Retinol (ug]dl) Taken Post Intervention |
31.8; 25.1 | <0.000 sig |
| SECONDARY Percentage of Underweight Participants |
49; 48; 35; 44 | 0.7 |
| SECONDARY Percentage of Participants With Stunted Growth |
55; 57; 62; 61 | 0.62 |
| SECONDARY Percentage of Participants With Wasted Growth |
24; 24; 13; 15 | 0.93 |
Summary
The purpose of this study is 1) to evaluate the effectiveness in reducing anemia among children 6-24 months of age by providing daily micronutrient Sprinkles through the Government of Pakistan's Lady Health Worker program; 2) to assist in the monitoring the National Sprinkles Pilot Project.
Eligibility Criteria
Inclusion Criteria
- Child's mother gives written consent after hearing an explanation of the study
- Random selection of child in household with more than one eligible child
Exclusion Criteria
- Any household in which consent is not given
- Children with any congenital or physical disability (such as cleft palate, Down's Syndrome, etc.)
- Child from a family which intends to migrate during the study period
Data sourced from ClinicalTrials.gov (NCT00659061). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.